About this guide
Infrared Material Guide examines how CELLIANT-related material and study statements should be scoped. It is not Hologenix, CELLIANT, a United States regional office, an authorized agent, distributor, or reseller.
Hologenix, LLC owns CELLIANT as an infrared textile ingredient technology. That relationship matters because a guide, fabric mill, finished-goods brand, marketplace listing, and official technology owner do not have interchangeable authority.
The mineral formulation may be embedded into fibers or yarns, incorporated through downstream textile construction, or applied through a topical print route. Each path needs its own loading, identity, durability, and test context.
Ash or XRF can address presence; emissivity addresses radiative behavior under a stated setup; TcPO2 or HSI addresses defined physiological endpoints under human-study conditions. None is a universal certificate of every benefit.
Population, sample size, comparator, duration, anatomical site, textile construction, endpoint, uncertainty, and publication status should remain visible. Removing those details changes the meaning of the evidence.
Official brand pages can define identity and current product language. A clinical paper can describe a specific study. A regulator's communication defines its own scope. We do not treat these sources as equivalent.
Useful summaries retain the carrier, loading, specimen, protocol, population, endpoint, and limitations. Qualifiers are information, not clutter.
We provide an independent reading framework. We do not manufacture CELLIANT materials, license the technology, inspect production, confirm partners, or offer regulatory approval.
Current carrier availability, prescribed loading, authorized documentation, licensing status, and official claim language belong with Hologenix.
Actual yarn, fabric construction, finish, lot, width, GSM, color, process conditions, and product-specific quality records belong with the producer.
Method version, conditioning, equipment, specimen, uncertainty, result, and report scope belong with the named laboratory or investigators.
Final intended-use wording, labeling, jurisdiction, and regulatory responsibilities require competent review for the exact product and market.
Use our framework to ask better questions. Obtain current first-party documentation before making a purchase, licensing, compliance, clinical, or product-claim decision.
Open the standards framework